ASP3082

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASP3082, covering 2026-03-27 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ASP3082 in Adults With Advanced Solid Tumors [Phase 1]